Bridge Biotherapeutics to Present Tuesday at the BIO International Convention

Logo BenzingaBenzinga
2023-06-02 18:34:00  • 3 mins

Bridge Biotherapeutics Inc. (KQ288330), a South Korean clinical-stage biotechnology company focused on developing novel drugs for cancer, fibrosis and inflammation, will present an overview of its pipeline in multiple disease states on Tuesday, June 6 at the 2023 BIO International Convention taking place in Boston June 5-8.

This press release features multimedia. View the full release here:

Pavel Printsev, Director of Business Development, will provide a overview of the company's science and an introduction to its clinical-stage assets:

  • BBT-176 -- Fourth-generation EGFR TKIs for non-small cell lung cancer active against C797S resistance mutations, currently in a Phase I/II dose escalation study
  • BBT-877 -- Autotaxin inhibitor for idiopathic pulmonary fibrosis, currently in a Phase IIa trial
  • BBT-207 -- Fourth-generation EGFR TKIs for non-small cell lung cancer active against C797S resistance mutations, which recently received FDA clearance for a first-in-human Phase I/II

Mr. Printsev will also give an overview of Bridge Biotherapeutics' newly acquired biosensing technology and its plans to commercialize these novel capabilities.

Continue read on

Intellia Therapeutics (NASDAQ: NTLA) and Rocket Pharmaceuticals (NASDAQ: RCKT) are gene-editing biotechs that want to offer what few others can: cures for...
British scientists are using pioneering stem cell technology to grow mini-brains in a laboratory to trial a large range of potential new treatments for...
Logo Daily MailDaily Mail
2023-09-23 21:01:02  • 1 min
In our modern age, the power of gene editing is undeniable. After years of foundational scientific research, it's now becoming possible to treat illnesses...
Logo NasdaqNasdaq
2023-09-23 12:45:00  • 1 min
Fintel reports that on September 22, 2023, Guggenheim reiterated coverage of Immunovant ( NASDAQ:IMVT ) with a Buy recommendation. Analyst Price Forecast...
Logo NasdaqNasdaq
2023-09-23 20:09:34  • 1 min
Bone marrow cancer patients will now be able to receive a treatment that extends life after NHS spending chiefs U-turned on their decision not to fund it....
Logo Daily MailDaily Mail
2023-09-23 21:00:52  • 1 min
(RTTNews) - Merck & Co Inc. (MRK), known as MSD outside of the U.S. and Canada, announced Friday positive topline results from the Phase 3 KEYNOTE-A39...
Logo NasdaqNasdaq
2023-09-22 10:59:35  • 1 min
UNITED NATIONS (AP) It's Day 5 of the U.N. General Assembly high-level meeting that brings world leaders together at U.N. headquarters in New York. Here are...
Health care stocks were steady pre-bell Friday, with the Health Care Select Sector SPDR Fund ( XLV ) and iShares Biotechnology ETF ( IBB ) recently...
Logo NasdaqNasdaq
2023-09-22 13:13:28  • 1 min
(RTTNews) - Abbott Laboratories (ABT) announced Wednesday an agreement with Spain-based global biotech firm mAbxience Holdings S.L. to commercialize several...
Logo NasdaqNasdaq
2023-09-20 12:34:23  • 1 min
(RTTNews) - Seagen Inc. (SGEN) and Astellas Pharma Inc. reported positive topline results from the Phase 3 EV-302 trial for PADCEV in combination with...
Logo NasdaqNasdaq
2023-09-22 09:51:30  • 1 min
Fintel reports that on September 22, 2023, Needham reiterated coverage of Harmony Biosciences Holdings ( NASDAQ:HRMY ) with a Buy recommendation. Analyst...
Logo NasdaqNasdaq
2023-09-23 20:09:58  • 1 min
Investment fund Guinness Global Innovators makes money for investors by taking stakes in companies that are involved in leading edge technology everything...
Logo Daily MailDaily Mail
2023-09-23 20:52:00  • 2 mins
Although the next general election may be more than a year away, the main parties are already beginning to outline positions on key issues a process likely...
Logo The GuardianThe Guardian
2023-09-23 07:00:22  • 1 min
Pharmaceutical companies are harnessing artificial intelligence (AI) to speed up the traditionally arduous process of clinical trials, potentially saving...
Logo BenzingaBenzinga
2023-09-22 11:49:07  • 1 min
Health care stocks were slightly higher late Friday afternoon with the NYSE Health Care Index up 0.1% and the Health Care Select Sector SPDR Fund (XLV)...
Logo NasdaqNasdaq
2023-09-22 19:48:37  • 1 min
A top-ranking Food and Drug Administration official, responsible for overseeing the approvals of the new vaccines now rolling out for this fall and winter's...
Logo CBS NewsCBS News
2023-09-22 15:11:45  • 1 min
A doctor working for the US government visited the Wuhan facility which has faced questions over the origins of Covid-19 and raised safety concerns almost...
Logo Daily MailDaily Mail
2023-09-22 23:40:57  • 1 min
Luke Donald says the purity of the Ryder Cup will lift it above all the bitterness and rage that has divided golf in the past two years. With the...
Logo Daily MailDaily Mail
2023-09-23 23:04:39  • 1 min
(RTTNews) - Merck (MRK) announced the FDA has accepted and granted priority review for a supplemental new drug application seeking approval for WELIREG for...
Logo NasdaqNasdaq
2023-09-19 11:36:13  • 1 min
The last time Team USA attempted to break its drought on European soil, Tiger Woods was leading the mission. Fast forward five years and his appearance in...
Logo Daily MailDaily Mail
2023-09-23 11:13:24  • 1 min